Detalhe da pesquisa
1.
Pharmacological modulation of RB1 activity mitigates resistance to neoadjuvant chemotherapy in locally advanced rectal cancer.
Proc Natl Acad Sci U S A
; 121(6): e2304619121, 2024 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38289962
2.
Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer.
N Engl J Med
; 388(18): 1657-1667, 2023 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37133585
3.
UGT1A1 genotype-guided irinotecan dosing during neoadjuvant chemoradiotherapy for locally advanced rectal cancer: A prospective analysis of SN-38 concentration.
Int J Cancer
; 154(8): 1484-1491, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38158593
4.
Prognostic and predictive impact of metastatic organ involvement on maintenance therapy in advanced metastatic colorectal cancer: Subgroup analysis of patients treated within the PanaMa trial (AIO KRK 0212).
Int J Cancer
; 154(5): 863-872, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37840339
5.
A phase II study of guadecitabine combined with irinotecan vs regorafenib or TAS-102 in irinotecan-refractory metastatic colorectal cancer patients.
Int J Cancer
; 154(10): 1794-1801, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38312102
6.
Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies: individual patient data pooled analysis of randomised trials from the ARCAD database.
Br J Cancer
; 130(8): 1269-1278, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38402342
7.
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study.
Lancet
; 402(10395): 41-53, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37331369
8.
Trifluridine/Tipiracil Plus Bevacizumab for Vulnerable Patients With Pretreated Metastatic Colorectal Cancer: A Retrospective Study (WJOG14520G).
Oncologist
; 29(3): e330-e336, 2024 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37950903
9.
The efficacy and safety of short-course radiotherapy followed by sequential chemotherapy and Cadonilimab for locally advanced rectal cancer: a protocol of a phase II study.
BMC Cancer
; 24(1): 501, 2024 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38641773
10.
Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer.
BMC Cancer
; 24(1): 16, 2024 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38166764
11.
High serum proteinase-3 levels predict poor progression-free survival and lower efficacy of bevacizumab in metastatic colorectal cancer.
BMC Cancer
; 24(1): 165, 2024 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38308214
12.
Anus preservation in low rectal adenocarcinoma based on MMR/MSI status (APRAM): a study protocol for a randomised, controlled, open-label, multicentre phase III trial.
BMC Cancer
; 24(1): 57, 2024 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38200410
13.
Clinical, Functional, and Nutritional Efficacy of a Glutamine-Enriched Oligomeric Diet in Patients with Rectal Cancer.
Nutr Cancer
; 76(1): 128-136, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-37994411
14.
Case report outcome of cetuximab treatment in a metastatic colorectal cancer patient with novel KRAS P34R.
Anticancer Drugs
; 35(2): 195-198, 2024 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38018809
15.
Twelve-month progression-free survival with sotorasib and panitumumab in KRAS G12C mutant metastatic colorectal cancer.
Anticancer Drugs
; 35(5): 459-461, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38451823
16.
Incidence of Secondary Cancers After Neoadjuvant Therapy for Locally Advanced Rectal Cancer.
J Surg Res
; 295: 268-273, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38048750
17.
Completion total mesorectal excision after neoadjuvant radiochemotherapy and local excision for rectal cancer.
Colorectal Dis
; 26(2): 281-289, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38131642
18.
Metabolic Signatures: Pioneering the Frontier of Rectal Cancer Diagnosis and Response to Neoadjuvant Treatment with Biomarkers-A Systematic Review.
Int J Mol Sci
; 25(4)2024 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38397058
19.
[Exploration of the method and efficacy of treatments for intractable pelvic pain caused by rectal or bladder fistula].
Zhonghua Zhong Liu Za Zhi
; 46(3): 263-268, 2024 Mar 23.
Artigo
em Zh
| MEDLINE | ID: mdl-38494773
20.
[A Case of Pathologically Complete Response after Preoperative Chemotherapy in a Locally Advanced Rectal Cancer].
Gan To Kagaku Ryoho
; 51(3): 332-333, 2024 Mar.
Artigo
em Japonês
| MEDLINE | ID: mdl-38494822